++
Chapter 22. Dyslipidemia Medication Therapy Management Data Set
++
++
++
Which of the following lipid markers remains valid if the patient is not fasting at the time the lipid panel is completed?
++
++
++
++
++
++
++
++
++
++
++
++
Each of the following is considered a CHD risk equivalent EXCEPT:
++
++
++
a. Congestive heart failure
++
++
++
++
c. Abdominal aortic aneurysm
++
++
d. Peripheral arterial disease
++
++
++
Which of the following LDL goals is appropriate for a patient diagnosed with type 2 diabetes mellitus?
++
++
++
++
++
++
++
++
++
++
++
++
Which of the following would best describe rhabdomyolysis in living room language?
++
++
++
a. A serious degradation of muscle tissue caused by statins. It is associated with myalgias and myoglobinuria.
++
++
b. A severe condition where the muscles are breaking down. This presents with muscle weakness and pain, along with cola-colored urine.
++
++
c. A potential side effect of HMG-CoA reductase inhibitors. The patient may experience muscle pain (myalgia), weakness, or cramps.
++
++
d. Something bad that happens, a bad reaction, or an unexplained or unwanted effect.
++
++
++
JJ is a 42-year-old man with dyslipidemia who is new to your MTM service. After completing a medication therapy review with JJ, you complete a MAP. Which of the following statements best represents the type of information you should include in JJ's MAP?
++
++
++
a. Simvastatin 20 mg tablet: take nightly for cholesterol
++
++
b. Side effects you may experience with this medication include myalgias, myopathy, and rhabdomyolysis
++
++
c. Remember to take your simvastatin every night; try using a pillbox or alarm reminder to help you remember
++
++
d. The pharmacist will call your doctor to discuss switching your simvastatin to a stronger medication for your high cholesterol
++
++
++
All of the following would indicate the need for referral to the emergency department EXCEPT:
++
++
++
a. The patient is experiencing severe chest pain that is radiating ...